Remove tag medicines-spending
article thumbnail

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. has the condition; it is responsible for 300,000 premature deaths/year and $330 billion in annual healthcare spending. 9% of the U.S.

article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

million price tag. But the justification for Roctavian’s cost will depend on positive responses to the treatment, says Dr. Guy Young, professor of pediatrics at University of Southern California’s Keck School of Medicine. The post Can gene therapies for haemophilia defend their high price tags? million ($1.8

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds September 29, 2023: Navigating the Use of Patient-Reported Outcomes in Research and Practice: The PROTEUS Consortium (Claire Snyder, PhD; Norah Crossnohere, PhD; Anne Schuster, PhD)

Rethinking Clinical Trials

There was discussion about paying patients and patient advocates for the time they spend advocating for PROs. Some of the discussion included insurance coverage where PRO monitoring is included with a prescribed treatment plan. In terms of marketing, including patient preferences in marketing throughout. We are pursuing funding.

article thumbnail

Grand Rounds August 4, 2023: AI & ML: Want to Play a Game? (Eric Perakslis, PhD)

Rethinking Clinical Trials

However, Dr. Perakslis advocates that “instead of spending time and energy solving small problems, we should be solving big problems with bold solutions.” It’s important that people apply good judgement when utilizing these new technologies, especially in fields of science and medicine.

article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry.

article thumbnail

Grand Rounds September 15, 2023: Effect of Financial Incentives and Default Options on Food Choices of Adults With Low Income in Online Retail Settings (Pasquale Rummo, PhD, MPH)

Rethinking Clinical Trials

As far as the savings go, I looked at substitution spending in a prior study, and at least for other grocery orders, people didn’t substitute to some of the unhealthy categories. For this study, people are ultimately buying more fruits and vegetables regardless of what they choose to spend their savings on.

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Brands spend a huge amount of time and effort building hyper-relevant content relationships with their customers.”. Jeremy Richter, Tag.

Branding 118